Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bagyinszky, Eva | - |
dc.contributor.author | Vo Van Giau | - |
dc.contributor.author | Shim, Kyuhwan | - |
dc.contributor.author | Suk, Kyoungho | - |
dc.contributor.author | An, Seong Soo A. | - |
dc.contributor.author | Kim, SangYun | - |
dc.date.available | 2020-02-27T18:43:29Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-05-15 | - |
dc.identifier.issn | 0022-510X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/6123 | - |
dc.description.abstract | Alzheimer's disease (AD) is a complex disorder and the most common form of neurodegenerative dementia. Several genetic, environmental, and physiological factors, including inflammations and metabolic influences, are involved in the progression of AD. Inflammations are composed of complicated networks of many chemokines and cytokines with diverse cells. Inflammatory molecules are needed for the protection against pathogens, and maintaining their balances is important for normal physiological function. Recent studies demonstrated that inflammation may be involved in neurodegenerative dementia. Cellular immune components, such as microglia or astrocytes, mediate the release of inflammatory molecules, including tumor necrosis factor, growth factors, adhesion molecules, or chemokines. Over- and underexpression of pro- and anti-inflammatory molecules, respectively, may result in neuroinflammation and thus disease initiation and progression. In addition, levels of several inflammatory factors were reported to be altered in the brain or bodily fluids of patients with AD, reflecting their neuropathological changes. Therefore, simultaneous detection of several inflammatory molecules in the early or pre-symptomatic stage may improve the early diagnosis of AD. Further-studies are needed to determine, how induction or inhibition of inflammatory factors could be used for AD therapies. This review summarizes the role or possible role of immune cells and inflammatory molecules in disease progression or prevention. (C) 2017 Elsevier B.V. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.relation.isPartOf | JOURNAL OF THE NEUROLOGICAL SCIENCES | - |
dc.subject | COLONY-STIMULATING FACTOR | - |
dc.subject | TUMOR-NECROSIS-FACTOR | - |
dc.subject | AMYLOID PRECURSOR PROTEIN | - |
dc.subject | LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE-A2 | - |
dc.subject | INTERLEUKIN-1 RECEPTOR ANTAGONIST | - |
dc.subject | PLATELET-ACTIVATING-FACTOR | - |
dc.subject | MILD COGNITIVE IMPAIRMENT | - |
dc.subject | TRANSGENIC MOUSE MODEL | - |
dc.subject | NERVE GROWTH-FACTOR | - |
dc.subject | STEM-CELL FACTOR | - |
dc.title | Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000401210500048 | - |
dc.identifier.doi | 10.1016/j.jns.2017.03.031 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE NEUROLOGICAL SCIENCES, v.376, pp.242 - 254 | - |
dc.identifier.scopusid | 2-s2.0-85016398959 | - |
dc.citation.endPage | 254 | - |
dc.citation.startPage | 242 | - |
dc.citation.title | JOURNAL OF THE NEUROLOGICAL SCIENCES | - |
dc.citation.volume | 376 | - |
dc.contributor.affiliatedAuthor | Bagyinszky, Eva | - |
dc.contributor.affiliatedAuthor | Vo Van Giau | - |
dc.contributor.affiliatedAuthor | An, Seong Soo A. | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Inflammation | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Oxidative stress | - |
dc.subject.keywordAuthor | Neurodegeneration | - |
dc.subject.keywordAuthor | Neuroprotection | - |
dc.subject.keywordPlus | COLONY-STIMULATING FACTOR | - |
dc.subject.keywordPlus | TUMOR-NECROSIS-FACTOR | - |
dc.subject.keywordPlus | AMYLOID PRECURSOR PROTEIN | - |
dc.subject.keywordPlus | LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE-A2 | - |
dc.subject.keywordPlus | INTERLEUKIN-1 RECEPTOR ANTAGONIST | - |
dc.subject.keywordPlus | PLATELET-ACTIVATING-FACTOR | - |
dc.subject.keywordPlus | MILD COGNITIVE IMPAIRMENT | - |
dc.subject.keywordPlus | TRANSGENIC MOUSE MODEL | - |
dc.subject.keywordPlus | NERVE GROWTH-FACTOR | - |
dc.subject.keywordPlus | STEM-CELL FACTOR | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.